7 June 2022
—
Expert views on new data for the management of mNSCLC in June 2022
june2022updates~Lung cancer
EM-86783
7 June 2022
—
Expert views on prostate cancer news from June 2022
june2022updates~Prostate cancer
EM-86737
16 June 2022
—
Is it practice changing? A discussion on bladder cancer news from June 2022
Bladder cancer~june2022updates~Urothelial cancer
EM-87596
1 July 2022
—
Looking towards the future: considerations for treatment strategies across the spectrum of advanced prostate cancer
Janssen sponsored industry session at EAU 2022
Prostate cancer
EM-86726
13 July 2022
—
Enquiring minds: a comprehensive overview of genomic profiling from tissue to liquid biopsy
Lung cancer
EM-86791
13 September 2022
—
Experts’ views on prostate cancer news from September 2022
Prostate cancer
EM-86741
13 September 2022
—
An evolving landscape: EGFR+ NSCLC management updates from September 2022
Lung cancer
EM-86796
21 September 2022
—
Under the spotlight: A review of recent bladder cancer news from September 2022
Bladder cancer~Urothelial cancer
EM-87601
15 November 2022
—
Where do we stand with personalized medicine in 2022?
Prostate cancer
EM-86756
1 December 2022
—
That’s a wrap! A review of bladder cancer news in 2022
Bladder cancer~Urothelial cancer
EM-87605